First Trust NYSE Arca Biotechnology Index Fund
257 hedge funds and large institutions have $576M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 97 reducing their positions, and 23 closing their positions.
39% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 23
7% more capital invested
Capital invested by funds: $536M → $576M (+$40.1M)
2% more funds holding
Funds holding: 251 → 257 (+6)
0.58% more ownership
Funds ownership: 48.69% → 49.28% (+0.58%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
44% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 97
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$9.7M |
| 2 |
CWM
Congress Wealth Management
Boston,
Massachusetts
|
+$6.99M |
| 3 |
GSIAS
Garden State Investment Advisory Services
Red Bank,
New Jersey
|
+$4.33M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$3.78M |
| 5 |
BEI
Benjamin Edwards Inc
Clayton,
Missouri
|
+$3.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$30.3M |
| 2 |
Jane Street
New York
|
-$6.49M |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$5.81M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.77M |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$3.73M |
FBT Hedge Fund Activity: Q3 2024 in Review
257 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2024, worth a combined $576M — up 7.5% from $536M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new FBT positions and 23 closed out — a net gain of 9 holders — while 54 added to existing stakes and 97 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $9.7M. The largest seller was Wells Fargo, cutting an estimated $30.3M.
- 257 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2024, up from 251 in Q2 2024.
- Funds reported $576M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2024, up 7.5% quarter-over-quarter.
- 32 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2024 and 23 closed out, a net change of +9 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2024 was Envestnet Asset Management, an estimated $9.7M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2024 was Wells Fargo, an estimated $30.3M sold.
Based on aggregated 13F filings for Q3 2024.